• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problems Difficult to Remove (1528); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/19/2023
Event Type  malfunction  
Event Description
It was reported that it was difficult to remove the stent delivery system from the patient.An eluvia eu, 6x120, 130 cm was selected for use in the superficial femoral artery (sfa) for the percutaneous angioplasty procedure.The target lesion was reported to be 90 percent stenosed, with moderate tortuosity and calcification.The target lesion was predilated prior to stent placement.After successfully deploying the stent in the sfa, the delivery system was attempted to be withdrawn, but it interfered with the 0.014 in micro guidewire, making removal difficult.The micro guidewire was removed first in order to proceed with the procedure.The procedure was completed and there were no adverse consequences reported to the patient.
 
Manufacturer Narrative
Device media analysis: returned product consisted of an eluvia self-expanding stent system from batch 29133956 with an unknown 0.014 in.Guidewire stuck in the device.The outer sheath, tip, inner sheath and the remainder of the device were checked for damage.Visual examination revealed that the sheath was kinked at the nosecone.Microscopic examination revealed no additional damages.The stent was deployed and did not return for analysis.The handle was x-rayed, and the proximal inner was prolapsed.Inspection of the remainder of the device, revealed no other damage or irregularities.In addition to the device analysis becoming available, additional information was provided regarding the device lot number and the origin of the micro guidewire.Sections b5 and d4 have been updated.
 
Event Description
It was reported that it was difficult to remove the stent delivery system from the patient.An eluvia eu, 6x120, 130 cm was selected for use in the superficial femoral artery (sfa) for the percutaneous angioplasty procedure.The target lesion was reported to be 90 percent stenosed, with moderate tortuosity and calcification.The target lesion was predilated prior to stent placement.After successfully deploying the stent in the sfa, the delivery system was attempted to be withdrawn, but it interfered with the 0.014 in non-bsc micro guidewire, making removal difficult.The micro guidewire was removed first in order to proceed with the procedure.The procedure was completed and there were no adverse consequences reported to the patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway MA
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16341866
MDR Text Key309276023
Report Number2124215-2023-05559
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/08/2024
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0029133956
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/07/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/14/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-